ORITAVANCIN (TenkasiĀ®)
Clinical Indication
Acute bacterial skin and skin structure infections (ABSSSI) in adults
Comments
Reviewed by TAS September 22
Date of classification
October 2022
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.